Listed
Stock Code: 335810
| Company Name | 프리시젼바이오(주) |
| English Name | Precision Biosensor Inc. |
| Business Reg. No. | 3148608943 |
| CEO | 김한신 |
| Address | 대전시 유성구 테크노2로 306 |
| Industry | 그 외 기타 의료용품 및 의약 관련제품 제조업 |
| Industry Code | 27199 |
| Main Products | 체외면역진단기기 및 진단용 시약 |
| Established | 2009-09-28 |
| Phone | 042-867-6300 |
| Website | precision-bio.com/ |
| Regular Employees | Contact |
| Corp. Reg. No. | 1601110265995 |
Venture Certified
| 기술평가보증기업(기금) | 2012-04-25 ~ 2014-04-24 | 20120103731 | 2012-04-25 |
| 벤처투자유형 | 2016-09-01 ~ 2018-08-31 | 20160300417 | 2012-04-25 |
| 벤처투자유형 | 2018-09-01 ~ 2020-08-31 | 20180300572 | 2012-04-25 |
| 벤처투자유형 | 2020-09-01 ~ 2022-08-31 | 20200300989 | 2012-04-25 |
| 벤처투자유형 | 2022-09-01 ~ 2025-08-31 | 20220811010005 | 2012-04-25 |
| 벤처투자유형 | 2025-09-01 ~ 2028-08-31 | 20250729010031 | 2012-04-25 |
Revenue CAGR +2.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 156.5B | 172.8B | 149.1B |
| Operating Profit | -32.9B | -25.0B | -38.9B |
| Net Profit | -47.2B | -29.1B | -62.0B |
| Total Assets | 543.4B | 622.7B | 561.1B |
| Total Liabilities | 247.6B | 287.6B | 235.5B |
| Total Equity | 295.8B | 335.1B | 325.6B |
Operating Loss: Op. profit -33B
3 Consecutive Years of Net Loss
▼ 2.7%
▼ 2.9%
▼ 3.6%
▲ 5.9%
▼ 15.0%
| Name | Position | Role |
|---|---|---|
| 김한신 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "김한신",
"certificate": [
{
"cert_number": "20120103731",
"changes": "",
"disclosure_date": "2012-04-25",
"first_cert_date": "2012-04-25",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-04-25 ~ 2014-04-24"
},
{
"cert_number": "20160300417",
"changes": "",
"disclosure_date": "2016-09-01",
"first_cert_date": "2012-04-25",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2016-09-01 ~ 2018-08-31"
},
{
"cert_number": "20180300572",
"changes": "",
"disclosure_date": "2018-08-23",
"first_cert_date": "2012-04-25",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2018-09-01 ~ 2020-08-31"
},
{
"cert_number": "20200300989",
"changes": "",
"disclosure_date": "2020-08-27",
"first_cert_date": "2012-04-25",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2020-09-01 ~ 2022-08-31"
},
{
"cert_number": "20220811010005",
"changes": "",
"disclosure_date": "2022-08-11",
"first_cert_date": "2012-04-25",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2022-09-01 ~ 2025-08-31"
},
{
"cert_number": "20250729010031",
"changes": "",
"disclosure_date": "2025-07-29",
"first_cert_date": "2012-04-25",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2025-09-01 ~ 2028-08-31"
}
],
"company_name": "프리시젼바이오(주)",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 5795663000,
"cost_of_sales": 10622151000,
"current_assets": 18464937000,
"current_liabilities": 19399493000,
"gross_profit": 4292310000,
"net_income": -6202852000,
"net_income_bs": -6208326000,
"non_current_assets": 37648382000,
"non_current_liabilities": 4149287000,
"non_operating_expenses": 3183902000,
"non_operating_income": 875943000,
"operating_profit": -3894893000,
"revenue": 14914461000,
"sga_expenses": 8187203000,
"total_assets": 56113319000,
"total_equity": 32564538000,
"total_liabilities": 23548781000
},
"2023": {
"capital_stock": 5807263000,
"cost_of_sales": 10551412000,
"current_assets": 14324603000,
"current_liabilities": 12658902000,
"gross_profit": 6725847000,
"net_income": -2910806000,
"net_income_bs": -2119044000,
"non_current_assets": 47945584000,
"non_current_liabilities": 16103733000,
"non_operating_expenses": 2099277000,
"non_operating_income": 1684966000,
"operating_profit": -2496495000,
"revenue": 17277259000,
"sga_expenses": 9222342000,
"total_assets": 62270187000,
"total_equity": 33507551000,
"total_liabilities": 28762636000
},
"2024": {
"capital_stock": 5807263000,
"cost_of_sales": 10096123000,
"current_assets": 13317088000,
"current_liabilities": 18594643000,
"gross_profit": 5558028000,
"net_income": -4717947000,
"net_income_bs": -4548793000,
"non_current_assets": 41026609000,
"non_current_liabilities": 6169046000,
"non_operating_expenses": 3125993000,
"non_operating_income": 1695897000,
"operating_profit": -3287851000,
"revenue": 15654152000,
"sga_expenses": 8845879000,
"total_assets": 54343697000,
"total_equity": 29580008000,
"total_liabilities": 24763689000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [
{
"amount": "7,999,917,000",
"changes": "7,999,917,000",
"date": "2019-08-22"
},
{
"amount": "1,336,000,000",
"changes": "1,336,000,000",
"date": "2019-08-22"
},
{
"amount": "445,000,000",
"changes": "445,000,000",
"date": "2019-08-22"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2019-08-22"
},
{
"amount": "1,999,998,000",
"changes": "1,999,998,000",
"date": "2019-08-22"
}
],
"main_products": "체외면역진단기기 및 진단용 시약",
"phone": "042-867-****",
"years": [
2024,
2023,
2022
]
}